Literature DB >> 17475353

Genomics and proteomics in process development: opportunities and challenges.

Prateek Gupta1, Kelvin H Lee.   

Abstract

Global gene expression profiling by genomic and proteomic analyses has changed the face of drug discovery and biological research in the past few years. The benefit of these technologies in the area of process development for recombinant protein production has been increasingly realized. This review discusses the application of genome-wide expression profiling tools in the design and optimization of bioprocesses, with the emphasis on the effect on process development of mammalian cell culture. Despite the lack of genome sequence information for most of the relevant mammalian cell lines used, these technologies can be applied during various process development steps. Although there are only a few examples in the literature that present a major improvement in productivity based on genomics and proteomics, further advances in analytical tools and genome sequencing technologies will greatly increase our knowledge at the molecular level and will drive the design of future bioprocesses.

Entities:  

Mesh:

Year:  2007        PMID: 17475353     DOI: 10.1016/j.tibtech.2007.04.005

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  9 in total

1.  Genomics, proteomics, MEMS and SAIF: which role for diagnostic imaging?

Authors:  R Grassi; R Lagalla; A Rotondo
Journal:  Radiol Med       Date:  2008-07-25       Impact factor: 3.469

2.  Why should genomic medicine become more evidence-based?

Authors:  Muin J Khoury; Linda A Bradley
Journal:  Genomic Med       Date:  2007-12-25

3.  Meta-analysis and functional validation of nutritional requirements of solventogenic Clostridia growing under butanol stress conditions and coutilization of D-glucose and D-xylose.

Authors:  Humberto Heluane; Matthew R Evans; Sue F Dagher; José M Bruno-Bárcena
Journal:  Appl Environ Microbiol       Date:  2011-05-20       Impact factor: 4.792

4.  Proteomic analysis of Chinese hamster ovary cells.

Authors:  Deniz Baycin-Hizal; David L Tabb; Raghothama Chaerkady; Lily Chen; Nathan E Lewis; Harish Nagarajan; Vishaldeep Sarkaria; Amit Kumar; Daniel Wolozny; Joe Colao; Elena Jacobson; Yuan Tian; Robert N O'Meally; Sharon S Krag; Robert N Cole; Bernhard O Palsson; Hui Zhang; Michael Betenbaugh
Journal:  J Proteome Res       Date:  2012-10-05       Impact factor: 4.466

5.  Use of proteomics for validation of the isolation process of clotting factor IX from human plasma.

Authors:  James Clifton; Feilei Huang; Dajana Gaso-Sokac; Kate Brilliant; Douglas Hixson; Djuro Josic
Journal:  J Proteomics       Date:  2009-10-09       Impact factor: 4.044

6.  The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.

Authors:  Steven M Teutsch; Linda A Bradley; Glenn E Palomaki; James E Haddow; Margaret Piper; Ned Calonge; W David Dotson; Michael P Douglas; Alfred O Berg
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

7.  Comparative proteomic profiles of Aspergillus fumigatus and Aspergillus lentulus strains by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).

Authors:  Claudine Pinel; Marie Arlotto; Jean-Paul Issartel; François Berger; Hervé Pelloux; Renée Grillot; Françoise Symoens
Journal:  BMC Microbiol       Date:  2011-07-28       Impact factor: 3.605

8.  Proteomic Analysis of Anti-Cancerous Scopularide Production by a Marine Microascus brevicaulis Strain and Its UV Mutant.

Authors:  Annemarie Kramer; Hans Christian Beck; Abhishek Kumar; Lars Peter Kristensen; Johannes F Imhoff; Antje Labes
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

9.  Accurate comparison of antibody expression levels by reproducible transgene targeting in engineered recombination-competent CHO cells.

Authors:  Patrick Mayrhofer; Bernhard Kratzer; Wolfgang Sommeregger; Willibald Steinfellner; David Reinhart; Alexander Mader; Soeren Turan; Junhua Qiao; Juergen Bode; Renate Kunert
Journal:  Appl Microbiol Biotechnol       Date:  2014-08-27       Impact factor: 4.813

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.